Apotex Corp

BENDAMUSTINE (APOTEX)

Manufacturer:

Apotex Corp

Bendamustine (Apotex) HCPCS:

J9058

HCPCS Code Descriptor:

Injection, bendamustine hydrochloride (apotex), 1 mg

Category:

J Code

Bendamustine (Apotex) NDCs:

60505-6228-00

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Bendamustine (Apotex):

BENDAMUSTINE (APOTEX) is a Oncology drug manufactured by Apotex Corp and administered via the Intravenous route of administration. The J Code: J9058 is aligned to the drug BENDAMUSTINE (APOTEX).

ACCESS PRICING AND MORE BY REGISTERING

J9058 Added Date:

July 1, 2023

J9058 Effective Date:

July 1, 2023

J9058 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Bendamustine (Apotex) billing and coding information.
Our team did not identify a source for Bendamustine (Apotex) patient assistance information. Please reach out to our team if you feel that this is a mistake.
BENDAMUSTINE (APOTEX) prescribing information can be found at the link below:
Our team has not yet identified a source of side effects information for BENDAMUSTINE (APOTEX). Please check back in a few weeks.